INS and Hypoglycemia: Fifth, the portosystemic and intrahepatic shunting, reduced insulin extraction, and decreased sulfonylurea metabolism due to cirrhosis may raise the risk of hypoglycemia in patients taking insulin or insulin secretagogues (27).